BIOCON LIMITED. (BIOCON) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

BIOCONUpdated 8 Sept 2026, 2:27

Biocon Limited.

Market Cap

₹63,810Cr.

Current Price

₹391

High / Low

₹447/337

Stock P/E

212

Book Value₹167
Dividend Yield0.13%
ROCE1.62%
ROE0.91%
Face Value₹5.00

About

Biocon is engaged in the business of manufacture of biotechnology products and research services.(Source : 202003-01 Annual Report Page No:195)

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days9080113112184105106147121180135156
Inventory Days148187190195371236197245208260296299
Days Payable109146159202298230170172169175288201
Cash Conversion Cycle129121144105257111133220159265143254
Working Capital Days764210887214154122181151244309
ROCE %17%10%8%4%5%5%5%2%2%3%2%2%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 8 September 2026 at 2:27


Designed & Shipped by Harshit Bansal